Breaking News

Waters and Genovis Enter Biopharmaceutical Partnership

Collaboration intended to bring speed and simplicity to bio-characterization workflows.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Waters Corporation and Genovis AB are collaborating to develop and market complete routine biopharmaceutical characterization workflows based on the Waters BioAccord LC-MS System, Andrew+ pipetting robot and Genovis SmartEnzymes. The goal of the collaboration is to develop automated workflows for the rapid and consistent characterization of critical quality attributes (CQAs) of monoclonal antibodies (mAbs) and other protein-based drugs in bioprocess development, formulation, stability testing an...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters